18F-FDG: clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving 18F-FDG

• 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
  NCT06503146 · Phase: Phase 2 · Ages: 18 Years to 120 Years · Sex: All (male and female) · 1 location
• 68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients
  NCT05549024 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Establishment and Clinical Transformation of ADC Drug Efficacy Evaluation System for Breast Cancer Based on Molecular Imaging
  NCT06715020 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Lung Nodule Detection Using Ultra-long FOV PET/CT
  NCT05463913 · Phase: Phase 4 · Ages: 18 Years to 100 Years · Sex: All (male and female) · 1 location
• NeuroFLiPP: Parametric PET of Neuroinflammation in Fatty Liver Disease
  NCT06453915 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve 18F-FDG?

5 recruiting trials across 15 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.